Insulet (PODD) Income from Continuing Operations (2010 - 2026)
Insulet's (PODD) quarterly Income from Continuing Operations came in at 91100000.0 in Q1 2026, up 156.62% YoY from 35500000.0 in Q1 2025, and down 10.42% on a QoQ basis from 101700000.0 in Q4 2025.
Insulet (PODD) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Insulet (PODD) has 17 years of Income from Continuing Operations data on file, last reported at 91100000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 156.62% year-over-year to 91100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 302900000.0 (down 24.71% YoY) and the FY2025 annual result came in at 247100000.0, down 40.93% from the prior year.
- Income from Continuing Operations fell to 91100000.0 in Q1 2026, from 101700000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 188600000.0 in Q2 2024 to a low of 35000000.0 in Q2 2022.
- A 5-year average of 56923529.41 and a median of 51500000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations plunged 141.27% — and 2023, when it surged 1098.08%.
- Tracing PODD's Income from Continuing Operations over 5 years: stood at 17000000.0 in 2022, then jumped by 508.24% to 103400000.0 in 2023, then dropped by 2.61% to 100700000.0 in 2024, then rose by 0.99% to 101700000.0 in 2025, then decreased by 10.42% to 91100000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 91100000.0 (Q1 2026), 101700000.0 (Q4 2025), and 87600000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Insulet | 10.34 Bn | 9.80 Bn | 562.60 Mn | 95.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 95.00 Mn |
| Mar 31, 2026 | 91.10 Mn |
| Dec 31, 2025 | 101.70 Mn |
| Sep 30, 2025 | 87.60 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | 35.50 Mn |
| Dec 31, 2024 | 100.70 Mn |
| Sep 30, 2024 | 77.50 Mn |
| Jun 30, 2024 | 188.60 Mn |
| Mar 31, 2024 | 51.50 Mn |
| Dec 31, 2023 | 103.40 Mn |
| Sep 30, 2023 | 51.90 Mn |
| Jun 30, 2023 | 27.30 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -35.00 Mn |
| Mar 31, 2022 | 27.80 Mn |
| Dec 31, 2021 | 29.20 Mn |
| Sep 30, 2021 | 12.60 Mn |